Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic Acid vs Risedronate in Paget's Disease of Bone
NCT00103740Phase 3Completed
- Sponsor
- Novartis
- Start
- Apr 2002
- Primary completion
- Dec 2003
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of zoledronic acid in Paget's disease of bone, sponsored by Novartis. Started Apr 2002; status: completed.
02
Drugs
zoledronic acid
03
Conditions
Paget's disease of bone
Beyond the preview
Go deeper on NCT00103740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00103740.